6Davenport JM, Schlain B. Testing claimed minimal detectable concentrations of in vitro medical diagnostic devices. J Clin Chemistry,2000,46(10): 1669 - 1680.
7Ni C, Zhang Z, Zhu X, et al. Prognostic value of CD166 expressionin cancers of the digestive system: a systematic review and meta analysis[J]. PLoS One, 2013,8(8):e70958.
8Sturgeon CM, Hoffman BR, Chan DW, et al. National Academy ofClinical Biochemistry.National Academy of Clinical BiochemistryLaboratory Medicine Practice Guidelines for use of tumor markersin clinical practice: quality requirements[J]. Clin Chem, 2008,54(8):1-10.
9Mattar R, Alves de Andrade CR, DiFavero GM, et al. Preoperativeserum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein inpatients with gastric cancer[J]. Rev Hosp Clin Fac Med Sao Paulo,2002,57(3):89-92.
10Cordero OJ, De Chiara L, Lemos-Gonzalez Y, et al. How the measurementsof a few serum markers can be combined to enhancetheir clinical values in the management of cancer [J]. AnticancerRes, 2008,28(4C):2333-2341.
